Russian Federation: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Russian Federation

The Russian human and animal blood market dropped sharply to $X in 2021, waning by -15.8% against the previous year. Overall, the total consumption indicated buoyant growth from 2012 to 2021: its value increased at an average annual rate of +5.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +61.0% against 2015 indices. As a result, consumption attained the peak level of $X, and then dropped rapidly in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Russian Federation

In value terms, human and animal blood production dropped dramatically to $X in 2021 estimated in export price. In general, production, however, posted a prominent increase. The pace of growth appeared the most rapid in 2020 when the production volume increased by 54%. As a result, production reached the peak level of $X, and then fell sharply in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from the Russian Federation

Human and animal blood exports from Russia skyrocketed to X tons in 2021, increasing by 20% against the previous year. Overall, total exports indicated strong growth from 2012 to 2021: its volume increased at an average annual rate of +7.0% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports decreased by -2.4% against 2019 indices. The pace of growth appeared the most rapid in 2016 when exports increased by 30%. The exports peaked at X tons in 2019; however, from 2020 to 2021, the exports stood at a somewhat lower figure.

In value terms, human and animal blood exports shrank modestly to $X in 2021. Over the period under review, exports showed a buoyant expansion. The most prominent rate of growth was recorded in 2016 with an increase of 58% against the previous year. The exports peaked at $X in 2018; however, from 2019 to 2021, the exports remained at a lower figure.

Exports by Country

Kazakhstan (X tons), Belarus (X tons) and India (X tons) were the main destinations of human and animal blood exports from Russia, with a combined 49% share of total exports. These countries were followed by the UK, Germany, Uzbekistan, Ukraine, Turkey, Tajikistan, Italy, Kyrgyzstan, the Netherlands and Armenia, which together accounted for a further 43%.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Turkey (with a CAGR of +494.4%), while the other leaders experienced more modest paces of growth.

In value terms, Kazakhstan ($X), Belarus ($X) and Uzbekistan ($X) were the largest markets for human and animal blood exported from Russia worldwide, together accounting for 54% of total exports. Ukraine, the UK, the Netherlands, India, Germany, Kyrgyzstan, Armenia, Tajikistan, Italy and Turkey lagged somewhat behind, together accounting for a further 36%.

Among the main countries of destination, the UK, with a CAGR of +298.1%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the average human and animal blood export price amounted to $X per ton, dropping by -18.4% against the previous year. Over the period under review, export price indicated a notable expansion from 2012 to 2021: its price increased at an average annual rate of +3.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2016 when the average export price increased by 22% against the previous year. Over the period under review, the average export prices attained the maximum at $X per ton in 2020, and then contracted notably in the following year.

There were significant differences in the average prices for the major export markets. In 2021, the country with the highest price was Ukraine ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Uzbekistan (+8.7%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into the Russian Federation

After two years of decline, overseas purchases of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses increased by 3.1% to X tons in 2021. In general, imports saw a relatively flat trend pattern. The growth pace was the most rapid in 2016 with an increase of 54%. Over the period under review, imports attained the maximum at X tons in 2018; however, from 2019 to 2021, imports failed to regain momentum.

In value terms, human and animal blood imports expanded significantly to $X in 2021. Overall, imports, however, saw a perceptible descent. The most prominent rate of growth was recorded in 2017 with an increase of 20%. Imports peaked at $X in 2013; however, from 2014 to 2021, imports stood at a somewhat lower figure.

Imports by Country

Denmark (X tons), Ukraine (X tons) and the United States (X tons) were the main suppliers of human and animal blood imports to Russia, with a combined 36% share of total imports.

From 2012 to 2021, the biggest increases were in Ukraine (with a CAGR of +35.7%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the UK ($X), Germany ($X) and France ($X) constituted the largest human and animal blood suppliers to Russia, with a combined 40% share of total imports. These countries were followed by Italy, Austria, Ireland, Denmark, Switzerland, Slovenia, the United States, the Netherlands, Ukraine and Bulgaria, which together accounted for a further 54%.

Among the main suppliers, Italy, with a CAGR of +30.4%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, rising by 2% against the previous year. In general, the import price, however, showed a pronounced shrinkage. The growth pace was the most rapid in 2017 an increase of 29%. The import price peaked at $X per ton in 2013; however, from 2014 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was the UK ($X per ton), while the price for Ukraine ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Austria (+9.4%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :